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The proliferation of helper T  cells and the T-dependent induction of B cell 
activation  are  events  that  are  initiated  by  T  cell  recognition  of antigen  in 
association with Ia glycoproteins. However, the molecular basis of helper T  cell 
antigen recognition remains unknown. Like several other laboratories, we have 
approached this problem by raising antibodies that are individually specific for 
functionally characterized cloned T  cell lines.  Clone-specific antibodies raised 
against alloreactive Ia-recognizing T  cell clones (1), antigen-Ia-specific helper T 
cell hybrids (2),  a  human cytotoxic HLA-A recognizing T  cell clone (3), and a 
murine H-2 recognizing cytotoxic T  cell clone (4) have already been described. 
These clone-specific antibodies are either stimulatory themselves, as is the case 
of antisera raised to alloreactive T  cell clones, or inhibit antigen-driven T  cell 
activation,  as  are  antibodies  raised  against  helper  T  cell  hybrids.  However, 
stimulatory antibodies  specific  for  major  histocompatibility complex  (MHC) 1 
restricted, antigen-specific cloned helper T  cell lines have not been described. In 
addition, the question of whether a monoclonal antibody of this specificity can 
activate a T  cell has never been addressed. 
In this paper,  we describe antisera that both activate the T  cells  themselves 
and induce T  cell-dependent B cell activation. In addition, we have produced a 
monoclonal antibody specific for a  single cloned helper cell line that can also 
activate the  T  cells of this  line.  The anti-clone antibodies we  have produced 
appear to completely replace the initial antigen-Ia recognition event by the T 
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cell, while apparently not affecting the growth factor requirements of the ensuing 
pathway of activation. These findings thus strongly support the supposition that 
clone-specific antibodies react with antigen and/or Ia recognition sites. 
The  experiments presented  here  utilize antisera  raised  against  two  cloned 
helper T  cell lines that have identical functional properties and genotype, but 
differ in nominal antigen specificity and in recognition of non-self Ia molecules. 
These antisera have high titer in biological assays and are absolutely specific for 
the immunizing clone. The ability of these sera, and the monoclonal antibody, 
to  activate the  appropriate  T  cell  is  dependent on  a  second  signal  from an 
accessory cell. The requirement for accessory cells,  however, can be eliminated 
by the addition of interleukin-1 (IL-1) or interleukin-2 (IL-2). Thus, this system 
allows the analysis of the activation of a homogeneous T  cell population in the 
complete absence of other cell types. Although similar to mitogen stimulation, 
the specificity of the interaction of T  cells with anti-clone antibodies should make 
this system more analogous to an antigen-driven reaction. The effect of clone 
specific anti-T cell sera on T-dependent B cell activation, the major function of 
T helper cells, has also not previously been studied. The clone-specific antibodies 
we describe allow T  cells to interact with B cells to induce B cell proliferation 
and immunoglobulin secretion in the absence of antigen recognition or MHC 
restriction.  Thus,  these  antibodies  mimic  many  facets  of  antigen-specific 
T  cell  interactions  with  Ia-bearing  cells,  and  should  allow  a  functional and 
ultimately molecular dissection of helper T  cell "behavior." 
Materials and Methods 
Animals. 
Animals were either purchased  from the Jackson  Laboratory, Bar Harbor,  ME, or 
raised in our colony at Yale University. All animals were between 2 and 6 mo of age at 
the time they were used. 
Production ofT Cell Clones D8 and D IO. 
To produce cloned helper T cell lines, the procedure of Sredni et al. (5) as modified 
by our laboratory (6) was followed. In this case, two AKR/J mice were primed, each with 
50 ug 5×-recrystallized hens egg albumin (OVA) (United States Biochemical Co., Cleve- 
land, OH) in complete Freund's adjuvant containing M. tuberculosis strain H37Ra (Difco 
Laboratories  Inc., Detroit,  MI). Mice were immunized in the hind footpads and base of 
the tail. 6 d later, the draining popliteal and inguinal lymph nodes were removed, the T 
cells purified by passage over Ig-anti-Ig (7) columns and cultured in Click's EHAA medium 
containing 200 #g/ml OVA and 5% fetal calf serum (FCS)selected for low mitogenicity. 
20  ×  10°lymph node T  cells were  cultured with  5  ×  108  mitomycin  C-inactivated 
syngeneic spleen cells in 25-cm  2 flasks for 3 d. The cells were then pelleted and resus- 
pended in Click's medium containing 20% FCS, 200 #g/ml OVA, and 0.33% agar (Difco 
Bacto Agar). This mixture was layered into a 60-mm petri dish containing 2 ml of 0.5% 
agar in Click's medium with 20% FCS and 200/~g/mi OVA. After several days, numerous 
clusters or colonies of cells appeared.  These were plucked  with a pasteur pipette  and 
transferred to a 96-well microtiter plate containing  Click's medium,  200 /~g/ml OVA, 
10% of a growth supporting FCS, 20%  rat Con  A supernatant as a source of growth 
factors and 2 x  105 mitomycin C-treated  syngeneic spleen cells/well. Most colonies gave 
rise to vigorous growth.  20 lines were expanded to 1-ml cultures in multiwell plates and 
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inactivated spleen cells.  19/20 gave significant responses to OVA. Two of these, D 10 and 
D8, were characterized extensively. D 10 was also recloned twice in succession by limiting 
dilution, first in U-bottom microtiter plates, where growth was obtained at low efficiency 
at 1 cell/well, and subsequently in V-bottom microtiter plates, where growth was obtained 
with close to  100% efficiency at 0.5 cells/well.  Clone D10.G4. I  was obtained from one 
of these wells.  Cells were expanded in 25 and 75 cm  2 tissue culture flasks fed twice per 
week with  medium  and antigen,  and  weekly with  5-10  x  105 mitomycin C-inactivated 
spleen  cells  per  milliliter  of culture.  Vigorous growth has been  maintained  for  18  mo 
under these conditions with these cloned lines.  Recently, we have found that the United 
States Biochemical Co. lot of OVA we have used contains conalbumin as a contaminant. 
D 10 and its subclones have since been demonstrated to exhibit antigen specificity for this 
protein,  and not ovalbumin, and are  currently maintained  using commercially purified 
conalbumin (Sigma Chemical Co.,  St.  Louis,  MO) as antigen.  D8 has been grown with 
various batches  of ovalbumin,  including  one  commercially prepared  lot  that  we  have 
found to be conalbumin free (Sigma Chemical Co.). 
Antibodies. 
Anti-DlO and Anti-D8.  Anti-T cell antisera  were produced by weekly immunizations 
of BALB.K mice with 3-10 x  106 cloned T  cells intraperitoneally in phosphate-buffered 
saline (PBS). Cloned T  cells were harvested 7-10 d after the last addition of feeder cells 
and washed  several  times  in  PBS before  injection.  Mice were bled  1 wk after  the  last 
immunization and  the  sera  collected and  tested.  After four injections with  D10,  or its 
subclones, the  immune sera had detectable  stimulatory activity in a  T  cell proliferation 
assay. These mice were subsequently boosted and bled on alternate weeks. Anti-D10 is a 
pooled serum from these animals,  derived from multiple bleeds.  Six out of six BALB.K 
mice have  produced anti-D10  activity by this  protocol. Two other  BALB.K mice also 
produced anti-D10 activity following a single boost 3 wk after priming. Two out of four 
(AKR x  B6)F1 mice have produced anti-Dl0 activity after six immunizations. The cloned 
T  cells (D10.G4.1) used to immunize these F1  mice were grown exclusively with AKR/J 
feeder cells. 
Two BALB.K mice were also immunized with  D8 cells by the above procedure.  One 
of these  mice produced  serum  with  detectable  activity after  the  seventh  immunization 
and was subsequently boosted. Anti-D8 is a pool of serum from this animal, derived from 
multiple bleeds. 
Monoclonal Anti-DlO Antibody (3D3).  A  BALB.K mouse was immunized with 5  x  106 
D10.G4.1  intraperitoneally  in  PBS  and  boosted  3  wk  later  with  4  ×  106  D10.G.4.1 
intravenously. 3 d  later  the immune spleen cells were fused to P3X63-Ag8.653 cells as 
described previously (8). The resulting hybridoma culture supernatants were screened for 
the induction of D 10.G4.1 proliferation in the absence of accessory cells and the presence 
of 1-5 % of an IL- 1 rich P388D 1 supernatent.  Out of 120 hybridomas screened,  1, 3D3, 
was positive in this assay. 3D3 was subsequently cloned on agar and by limiting dilution. 
~90%  of the  3D3  clones tested  (39  total)  were positive in  the  above assay.  Two agar 
clones,  3D3.1  and  3D3.2,  were  used  in  experiments  presented  here.  3D3  is an  IgGl- 
secreting hybridoma. 
Monoclonal Anti-Fc Receptor.  This  antibody,  2.4G2,  was  the  generous  gift  of Dr.  I. 
Mellman (Yale University, New Haven, CT) and has been described previously (9). 
Rabbit Anti-Mouse Brain (RaMBr).  RaMBr serum was produced as described previously 
(10). 
Assays. 
All assays, except the T-dependent induction of B cell immunoglobulin secretion, were 
performed in Click's medium containing 5% FCS. The induction of polyclonal immuno- 
globulin  secretion  was  performed  in  RPMI-1640  containing  10%  FCS  and  60  #M  2- 
mercaptoethanol.  All proliferation  assays were  harvested  with  a  PHD  Cell  Harvesting 
System (Cambridge Technology, Inc., Cambridge, MA). Other methods were as follows: 
T Cell Proliferation.  2  ×  10  `4 cloned T  cells were cultured in 0.2 ml containing feeder KAYE ET  AL.  839 
cells inactivated with mitomycin C (Sigma Chemical Co.) and various additions.  Feeder 
cells were either whole spleen cells (2 ×  105 cells/culture) or splenic adherent cells (2 × 
104 cells/culture). Splenic adherent cells were prepared by a modification of the method 
ofSteinman et al. (11). Briefly, whole spleen cells (1 ×  107 cells/ml in Dulbecco's Modified 
Eagle Medium containing 10% FCS) were allowed to adhere to plastic petric dishes (100 
mm; Costar,  Cambridge MA).  After 2  h  at 37°C,  nonadherent  cells were removed by 
gentle washing with warmed medium in the absence of FCS. Medium containing FCS was 
replaced and the incubation continued overnight at 37°C. At the end of this incubation 
period, adherent cells were harvested by vigorous pipetting with warmed medium. Cell 
yields range from 2-8% of the input cell number.  In some experiments soluble factors 
were added in place of feeder cells. Cultures were harvested after 72 h following a 3-4 h 
(70 Ci/mmol) or 16 h (6.7 Ci/mmol) 3H-TdR (New England Nuclear, Boston, MA) pulse 
of 1 ~Ci/culture. 
T-Dependent B  Cell Proliferation  and  Immunoglobutin  Secretion.  Cloned  T  cells  were 
inactivated with mitomycin C and added to B cells as previously described (12).  B cells 
were prepared by treatmt qt of whole spleen cells with a  rat monoclonal antibody that 
reacts with a  nonpolymorphic determinant  on  the  Thy-1  molecule followed by rabbit 
complement. Proliferation ~ as measured by a 4 h ~H-TdR pulse of 1 ~Ci/culture following 
a 48-h culture period. B cell immunoglobulin secretion was assayed in a plaque-forming 
cell assay as previously described (13),  culturing 3  ×  104 cloned T  cells and 4  ×  105 B 
cells in 0.2-ml cultures. Triplicate cultures were pooled and assayed by this method after 
3, 4, or 5 d in culture. 
IL-2 Assay.  The presence of IL-2 was determined by the ability to support the growth 
of the IL-2-dependent cell line HT-2, by a modification of the method of Gillis (14).  1 × 
104 HT-2 cells were cultured in 0.1  ml containing various amounts of supernatants to be 
assayed. Cultures were pulsed for the final 4 h  of a  24-h culture period with  1 ~Ci 3H- 
TdR/cuhure.  HT-2  cells  were  kindly  provided  by  Dr.  P.  Marrack  (National Jewish 
Hospital and Research Center, Denver, CO). 
Supernatant Factors. 
Con A-Induced  Spleen Cell Supernatant.  The production  of conconavalin  A  (Con  A) 
supernatants from rat spleen cells has been described previously (6). Residual Con A was 
inactivated by the addition of a-methyl-D-mannoside (20 mg/ml). 
AOFS Supernatants.  AOFS  21.10.9  cells were the  kind gift of Dr.  P.  Marrack.  IL-2 
containing supernatants  were produced  by incubating AOFS 21.10.9  cells at an initial 
concentration of 5 ×  10fi/ml with 2 t~g/ml Con A  for 24 h at 37°C in medium lacking 
FCS.  Supernatants  were  harvested  and  a-methyl-x)-mannoside (20  mg/ml)  was added 
before use. 
IL-I-Rich P388D1 Supernatant.  A  partially purified  IL-l-rich supernatant from lipo- 
polysaccharide (LPS)-induced P388D1  cells was the generous gift of Dr. S. Durum (Yale 
University New  Haven, CT).  The production and purification of this  supernatant has 
been described previously (15). Briefly, cultures of P388D 1 cells were stimulated 4 d with 
LPS  at a  concentration  of 20  #g/ml.  Supernatants  were  partially purified  by a  65% 
saturated ammonium sulfate precipitation followed by Sephadex G-75 chromatography. 
Biologic activity (thymocyte proliferation  assay) was  contained  in  the  15,000-20,000- 
dalton fractions. This source of IL-1 contains no detectable IL-2 (see Table V). 
Absorption ofAnti-DlO Mitogenic Activity.  1 ml of 1:1,000  anti-D10  diluted  in  Click's 
medium containing  5%  FCS was absorbed with 250 ~1 of protein A-coupled Sepharose 
(Pharmacia Fine Chemicals Co., Sweden) or bovine serum albumin (BSA)-coupled Seph- 
arose 4B (BSA coupled to CNBr-activated Sepharose at 1 mg protein/ml of Sepharose). 
After 1 h at 4°C with frequent mixing, the Sepharose was pelleted and the supernatant 
assayed for the ability to induce D10.G4.1  proliferation. The Sepharose beads used for 
absorption were extensively washed in PBS and eluted with 1 ml of 0.1  M sodium citrate 
pH 3.5 for 15 min at 4°C. This eluate was dialyzed against medium and also assayed for 
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Results 
DIO and D8 are Helper T Cell Clones. 
The cloned helper T  cell lines used in these studies have not been described 
previously; their production, recloning, and analysis are as follows: D 10 and D8 
are T  cell colonies produced from the pooled lymph node T  cells of two OVA- 
primed AKR/J  mice by the method of Sredni  et al.  (5),  as  modified by our 
laboratory (6).  The D10 clone D10.G4,  and its subclone D10.G4.1,  were pro- 
duced by the method of limiting dilution. Analysis by SDS-PAGE has recently 
revealed that the commercially obtained batch of 5× crystallized OVA (USBC) 
used for in vivo priming and in  vitro culturing of these clones was,  in fact, a 
mixture of chicken egg white proteins,  including conalbumin and  OVA.  Al- 
though we originally interpreted our data as demonstrating that  D10  showed 
antigen specificity for OVA (16), we have since, using purified egg white proteins, 
established that  the true antigen is conalbumin.  All subsequent references to 
OVA in this paper will refer to conalbumin-free OVA. Table I shows the antigen 
reactivity patterns of D8 and of D 10 and its subciones. D8 proliferates to OVA 
but not conalbumin in the presence of H-2 k feeder cells.  Conversely, D10 and 
its  subclones  proliferate  to  conalbumin,  but  not  OVA,  in  an  H-2-restricted 
manner. We have not observed alloreactivity with D8 when tested against eight 
independent haplotypes. D 10, however, was initially found to be alloreactive to 
H_2b.p. and q  Upon further cloning to yield D 10.G4 and D 10.G4.1, only reactivity 
to H-2  b has been maintained. 
Functionally, in vitro, D 10 and D8 induce hapten-specific plaque-forming cells 
in  the  presence  of low  doses  of haptenated  antigen  (reference  16,  and  K. 
Bottomly, personal communication). At high antigen doses, D10 and D8 induce 
polyclonal B cell proliferation and immunoglobulin secretion. As expected (12, 
16), all of these helper cell functions are antigen specific and H-2 restricted. 
Anti-clone Sera Are Mitogenic and Specific For the Immun&ing Clone.  In an attempt 
to identify cell surface molecules involved in helper cell functions, we have raised 
antisera against  D10  and,  more recently, against D8.  The choice of BALB.K 
mice as recipients for these immunizations eliminated the potential production 
of anti-H-2 antibodies that might have influenced screening assays, while favoring 
the production of antibodies directed against other alloantigens. Individual mice 
received 3-10  ×  106 cloned T  ceils intraperitoneally in PBS on a weekly basis. 
Mice were bled  1 wk after the last immunization, and the sera collected and 
assayed for the ability to  block or stimulate the proliferative response  of the 
appropriate T  cell clone. The antisera produced after four immunizations with 
D10 or its subclones was found to be mitogenic for the inducing clone. These 
mice were subsequently boosted and bled on alternate weeks. We have observed 
no qualitative differences in the activity of sera between individual mice immu- 
nized with a  single  D10  subclone, or between mice immunized with different 
D10 subclones. Anti-D10 refers to a pool of such sera that was used for all the 
experiments presented here. Anti-D8 was produced similarly, with the exception 
that no activity was detected until after the seventh immunization. We have not 
observed inhibition of antigen-induced T  cell proliferation with any of our sera. 
Fig.  1 summarizes an individual experiment measuring the proliferative re- KAYE  ET  AL.  841 
TABLE  I 
T Cell Clones DIO and D8 are H-2 Restricted and Antigen Specific: T Cell Proliferation 
A.  D10 and D8 proliferate to antigen in an H-2-restricted manner. 
D81  D10  D10.G4 
H-2I*  Feeders*  Antig  ens  Antigen  Antigen 
A,E 
--  +  --  +  --  + 
D10.G4.1 
Antigen 
--  + 
k,k  AKR  1,290  5,428 ~  457  15,232  1,122  10,993 
k,k  B10.BR  1,250  7,826  333  9,163 
k,k  B10.A  1,611  12,320 
k,k  B10.A(2R)  738  13,094 
b,b  B10  215  233  7,873  7,419 
b,b  C57B1/6  32,300  26,809  8,272  5,835 
b,k  B10.A(5R)  174  111  10,294  10,808  18,078  15,160 
d,d  BALB/C  299  156  529  1,321  2,859  2,046  558  659 
d,d  B10.D2  1,911  639  322  1,285 
(dxb)  CB6FI  1,226  251  12,968  12,635 
s,s  B10.S  176  356  1,064  3,414 
s,k  B 10.S(9R)  2,621  1,846 
p,p  B10.F(13R)  1,045  1,843  7,185  9,310  3,304  2,906 
q,q  B10.G  167  318  9,152  8,711  4,709  3,925 
r,r  B10.RIII  76  118  544  2,072  2,389  2,740 
f,f  B10.M  436  1,048  765  1,831  2,011  2,030 
B. D10 and D8 are antigen specific. 
T  Clone  !  Antigen  0  Response** 
D 10.G4.1  --  236 
D 10.G4.1  Conalbumin  14,237 
D 10.G4.1  OVA  338 
D8  --  45 
D8  Conalbumin  64 
D8  OVA  10,925 
* Haplotype of origin of the I-A and I-E subregions of various stimulator cells.  Strains with I-E  b''f'q 
express no I-E molecules on the cell surface. 
5  2 x  10  mitomycin C treated whole spleen cells/0.2 ml culture. 
200 #g/ml of OVA (DS) or conalbumin (D 10) added (+) or with no antigen (-). 
I 2 x  104 cloned T  cells/0.2 ml culture. 
Mean cpm SH-TdR incorporation of triplicate cultures, pulsed for the final 3 h of a 72-h culture 
period; significant stimulation underlined. 
** Mean cpm ~H-TdR incorporation in the presence of 2  x  l0  s mitomycin C-treated whole spleen 
cells as feeders. 
sponse  of D10.G4.1  and  D8  to  anti-D10  and  anti-D8.  Anti-D10  is  a  potent 
mitogen for DI0.G4.1  with a  titer greater than  1:1,000.  However, this serum 
has no effect even at high doses on D8 cells, despite the fact that in this particular 
experiment D8  gave a  more vigorous antigen response than  D10.G4.1.  Con- 
versely, anti-D8 stimulates D8 to proliferate while exhibiting no apparent effect 
on D 10.G4.1. The lower titer of anti-D8 may reflect a lower immunogenicity of 
these cells, consistent with the finding that a greater number of immunizations 
are required to induce the activity. Indeed, in recent experiments we have found 
that anti-D 10 can be induced following a single boost 3 wk after priming. 
To further examine the specificity of anti-D 10, we have assayed normal AKR Io 
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FIGURE  1.  Clone-specific antisera induce  T  cell  proliferation.  D10.G4.1  (D)  and  D8  (O) 
proliferation measured in a 72-h assay containing 2 x  104 cloned T cells and 2 x  105 mitomycin 
C-treated BALB.K whole spleen cells per 0.2 ml culture in the presence of various concentra- 
tions of anti-D10 (  ) or anti-D8 (  ..... ).  D10.G4.1  and  D8  antigen responses are assayed 
similarly, with the addition of conalbumin (D 10.G4.1) or OVA (DS) at 200 ug/ml (histograms). 
Data are expressed as mean cpm 3H-TdR incorporation of triplicate cultures following a  16-h 
pulse, 
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spleen cells,  lymph node cells, and  Con  A  blasts in a  proliferative assay.  In no 
case did anti-D10  induce  a  response  from  these  cells.  In  addition,  absorption 
with AKR spleen cells, Con A  blasts, or the AKR thymoma BW5147 does not 
remove any of the mitogenic activity directed at D 10.G4.1 (data not shown). We 
have  seen  significant  absorption  of anti-D10  activity  using  D10  cells,  and  no 
absorption with D8 cells, but the technical difficulty in obtaining large numbers 
of cloned cells has made these experiments  inconclusive.  These studies will  be 
repeated with D 10- and D8-derived T cell hybridomas currently being generated. 
Anti-D lO Mitogenic Activity Is Due to Antibody. 
Although nonimmune  BALB.K sera were not mitogenic for D10, we wanted 
to verify that antibody was responsible for the observed activity. Anti-D10  was 
diluted to a break point in activity and absorbed with protein A-coupled Sepha- 
rose or, as a control, BSA-coupled Sepharose. Only the protein A-Sepharose was 
able to remove the mitogenic activity for D10.G4.1 (Fig. 2A). In addition, activity 
was recovered in the acid eluate of the protein A-Sepharose (Fig. 2B). Therefore, 
the  ability  of this  serum  to  activate  D10.G4.1  is  the  property  of antibodies 
directed against the cloned T  ceil. 
Anti-clone Mitogenic Activity Requires Accessory Cells. 
Recent evidence suggests that the induction of T  cell proliferation by antigen 
or mitogen  is a  muhistep  process (17,  18).  Thus,  we asked  whether  anti-D10 
alone was sufficient to induce proliferation or whether a second signal from an 
accessory cell was also involved. Anti-D10  in the absence of accessory cells has 
almost  no  mitogenic  activity for  D10  or its subclones (Table  IIA).  The  slight KAYE  ET  AL.  843 
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FIGURE 5).  Anti-D10  mitogenic activity is specifically  removed by protein A-Sepharose. Left: 
1 ml of 1:1,000 anti-D 10 in medium was absorbed with 250 ~1 of protein A-Sepharose (O) or 
BSA-Sepharose (0). After 1 h on ice the mixture was centrifuged and the supernatant assayed 
for the ability to induce D10.G4.1 proliferation in a 72-h assay (see Fig. 1). Right: The protein 
A-Sepharose (O) or BSA-Sepharose (O) beads used for absorption were extensively washed 
and eluted with 1 ml of 0.1  M citrate pH 3.5. After dialysis against medium, the eluate was 
assayed as above. The data are expressed as the mean cpm 3H-TdR incorporation of triplicate 
cultures. 
residual activity seen is not a consistent finding and may represent minor feeder 
cell  contamination  of  the  T  cell  clone,  or  direct  accessory  cell-independent 
activation.  Anti-D8  also  requires  accessory  cells  to  induce  proliferation  (for 
example, see Table IV). In order to further characterize the cell involved in the 
anti-D10  response  we  have  used  spleen cells enriched by adherence  to plastic 
(splenic adherent cells) as accessory cells. This preparation contains a  variety of 
cell types.  10-fold fewer splenic adherent cells than spleen cells support an equal 
or better antigen response, consistent with the finding that such adherent cells 
are enriched for antigen-presenting  cells (19).  When  tested in  the presence of 
anti-D10, these same cells were also found to be enriched for cells that support 
D10.G4.1  proliferation (Table IIB). 
Although anti-D10 activity could not be absorbed out using spleen cells, and 
therefore was not likely to interact directly with the accessory cell population, it 
was possible that antibody aggregated on the T  cell surface was interacting with 
Fc receptors to induce a  second signal.  Particularly relevant is the finding that 
aggregated  immunoglobulin  can  induce  the  production  of IL-1  from  macro- 
phages (20).  The addition  of the  monoclonal anti-Fc receptor antibody  2.4G2 
(9),  however,  has  no  effect on  the  anti-D10  response  whether  spleen  cells  or 
splenic adherent cells are used as accessory cells (Table II C). Rabbit anti-mouse 
brain  (RaMBr)  is  known  to  be  mitogenic  for  T  cells,  and  RaMBr  mitogenic 
activity requires a  B  cell as accessory cell, and an  intact Fc (10).  Note that the 
proliferative response of D 10.G4.1  to RaMBr is almost totally eliminated in the 844  STIMULATORY ANTIBODIES  SPECIFIC  FOR  HELPER  T  CELL  CLONES 
TABLE  II 
Anti-D lO Mitogenic Activity Requires Splenic Adherent Accessory Cells 
A.  Mitogenic activity requires accessory cells. 
D 10*  H-2  k feeders*  Anti-D 10  ° 
Response ! 
D10  D10.G4  D10.G4.1 
Exp 1  Exp 2  Exp 3 
+  +  -  71  116  208 
+  +  +  29,269  27,431  7,984 
+  -  -  60  44  88 
+  -  +  786  946  1,150 
B.  Splenic adherent  cells are  enriched  for  cells that  support  anti-D10-induced  mitogenesis and 
present antigen. 
Response I 
D10.G4.1*  Addition  j  2 x  105  2 x  104 
Spl*  SAC  ~ 
+  --  474  146 
+  Conalbumin  7,750  14,727 
+  NMS  165  177 
+  Anti-D 10  9,749  12,579 
C.  Anti-Dl0 does not require interaction with Fc receptors to induce D10 proliferation. 
Response I 
D10.G4.1*  Antisera  0  Anti-FcR**  2 x  105  2 ×  104 
SpI*  SAC' 
+  --  -  42  92 
+  Anti-D10  -  14,377  13,931 
+  RaMBr  -  13,837  2,916 
+  --  +  32  46 
+  Anti-Dl 0  +  11,771  16,160 
+  RaMBr  +  71  273 
* 2 x  104 cloned T  cells/0.2 ml culture. 
* 2 x  105 mitomycin C-treated AKR]J or BALB.K whole spleen cells/0.2 ml culture. 
I NMS  and  Anti-D10  1:200-1:800  (concentration  of  NMS  and  anti-D10  are  identical  in  an 
individual experiment); RaMBr 1  : 150; conalbumin 200 #g/ml. 
! Mean cpm SH-TdR incorporation of triplicate cultures, pulsed for the final 16 h of a 72-h culture 
period. 
I 2 x  104 AKR/J or BALB.K splenic adherent cells/0.2 ml culture prepared as described in methods 
section  (both  spleen  cells and  adherent  cells are  derived  from  the  same  mouse  strain  in  an 
individual experiment). 
** Monoclonal antibody 2.4G2,  1 #g/ml. 
presence  of  2.4G2.  In  addition,  splenic  adherent  cells  are  not  enriched  for 
accessory  cells for the  RaMBr  response.  Although  2.4G2  is directed  against  the 
IgG2b/IgG1  receptor  (9),  it  also  binds  the  IgG2a  receptor  via  its  own  Fc  (I. 
Mellman,  personal  communication).  It remains  possible,  however,  the  anti-D10 
interacts  with  an  Fc receptor  not  blocked  by  this  monoclonal  antibody.  Finally, 
we asked whether  the interaction  with an accessory cell in the anti-D 10 and anti- 
D8 response  was  H-2 restricted.  The  experiments  in Table  III demonstrate  that 
while the antigen  responses  of D10.G4.1  and  D8 are  H-2  restricted,  there  is no 
apparent  restriction  in the anti-D10  and  anti-D8  responses. KAYE  ET  AL.  845 
Exp. 
I. 
II. 
Anti-clone-Induced Proliferation 
TABLE  III 
Does Not Require H-2 Matched Accessory Cells 
T  Clone*  Feeders*  Antigen  i  Antisera  !  Response  I 
D 10.G4.1  BALB.K  --  --  330 
D 10.G4.1  BALB.K  Conalbumin  --  6,552 
D10.G4.1  BALB.K  --  Anti-D10  10,072 
D 10.G4.1  BALB. K  --  Anti-D8  204 
D 10.G4.1  BALB/c  --  --  I 18 
D 10.G4.1  BALB/c  Conalbumin  --  133 
D 10.G4.1  BALB/c  --  Anti-D 10  11,725 
D8  BALB.K  --  --  45 
D8  BALB.K  OVA  --  10,925 
D8  BALB.K  --  Anti-D8  15,467 
D8  BALB.K  --  Anti-D10  36 
D8  BALB/c  --  --  85 
D8  BALB/c  OVA  --  154 
D8  BALB/c  --  Anti-D8  9,330 
* 2  X  104 cloned T  cells/0.2 ml culture. 
* Mitomycin C-treated whole spleen cells, 2  x  105/0.2 ml culture. 
Conalbumin or OVA 200 #g/ml or no antigen added (--). 
I Anti-D10  1:800; anti-D8  1:200. 
Mean cpm 3HTdR incorporation of triplicate cultures, pulsed for the final  16 h  of a  72-h culture 
period. 
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FIGURE  3.  Anti-D10 and a  Con A  supernatant synergize to induce D10.G4.1  proliferation 
in  the  absence  of accessory  cells.  D10.G4.1  proliferation  was  assayed  in  0.2-ml  cultures 
containing 2  x  104 cloned T  cells and: no addition (O),  15% Con A  supernatant (O), anti-D10 
1:500  (i), or anti-D 10 1:500 and 15% Con A supernatant (f-l). Data are expressed as the mean 
cpm 3H-TdR incorporation  of triplicate cultures pulsed for the final 4  h  of a  24-h, 48-h, or 
72-h culture period. 
IL-1- or IL-2-Rich Supernatants Can Replace Accessory Cells in the Response to 
Anti-clone Antibodies. 
The lack of genetic restriction between D 10 and the accessory cells in the anti- 
D10  response  suggested  to  us  that  a  lymphokine  might  be  involved  in  the 
activation of the T  cell clone. We therefore tested whether a Con A-induced rat 
spleen cell supernatant would be sufficient to support an anti-D 10 response. Fig. 
3 shows the kinetics of such an assay in the absence of accessory cells.  Clearly, 
anti-D10 and a Con A supernatant will synergize to induce D10.G4.1  prolifera- 846  STIMULATORY ANTIBODIES SPECIFIC  FOR  HELPER  T  CELL CLONES 
TABLE  IV 
IL-1-Rich Supernatant Supports Anti-clone-dependent  T Cell Proliferation in the Absence of 
Accessory Cells 
I L- 1  -Rich  Resp  °nsea 
Exp.  T Clone*  superna-  -- 
tant  ,  Anti.D10 !  Anti.D8!  Anti- 
gen ! 
I  D10.G4.1  -  37  878  ND**  ND 
D10.G4.1  +  159  49,929  ND  ND 
D10.G4.1  -  +LPS  ~  ND  1,256  ND  ND 
II  D10.G4.1  -  491  329  ND  133 
D10.G4.1  +  33  33,194  ND  32 
III  D10.G4.1  -  113  1,427  ND  92 
D10.G4.1  +  87  161,144  120  190 
IV  D8  -  43  ND  104  ND 
D8  +  49  ND  31,772  ND 
V  D8  -  43  ND  168  53 
D8  +  48  ND  31,422  33 
* 2 x  104 cloned T cells/0.2  ml culture. 
* Presence (+) or absence (-) of 1% IL-1 rich P388D1  supernatant. 
§ Mean cpm SH-TdR incorporation of triplicate cultures, pulsed for the final 16 h of a 72-h culture 
period. 
! Conalbumin (D 10.G4.1) or OVA (D8), 200 ug/ml; anti-D 10 1:800; anti-D8  1:200. 
LPS, 50 ~zg/ml. 
** Not done. 
tion. Con A-induced supernatants contain many soluble mediators including IL- 
2  and  IL-1.  The  role  of these  proteins  in  the  activation  of T  cells  has  been 
extensively  studied.  It  is  generally  accepted  that  antigen  and  Ia  glycoproteins 
trigger  a  T  cell  to  become  receptive  to  IL-1  released  by  activated  antigen- 
presenting  cells.  IL-1,  in  turn,  induces  the  T  cell  production  of  the  actual 
mitogenic  signal  IL-2  (reviewed  in  reference  21).  It  is  not  known  at  this  time 
whether  the  induction  of receptivity  to  IL-2  is  also  IL-1  dependent.  It was  of 
interest to compare this proposed mechanism of activation to that observed with 
anti-clone antisera.  If such antisera trigger the T  cell clone in a manner analogous 
to antigen  and  Ia, one might expect that anti-clone sera in the presence of IL-1 
would be sufficient to trigger proliferation.  This is indeed the case.  The experi- 
ments in Table  IV demonstrate  that in the absence of accessory cells, a  partially 
purified I L-l-rich P388D 1 supernatant will induce D 10.G4.1 or D8 to proliferate 
only in the presence of the appropriate  anti-clone sera.  LPS, the inducing agent 
for the production of IL- 1 from P388D 1 cells, and a possible contaminant of the 
preparation  used,  has  no  effect.  We  are  currently  testing  whether  this  IL-1- 
induced proliferation  is mediated by endogenously produced IL-2. 
Although IL-1 can replace accessory cells in an anti-clone response,  it can not 
replace antigen-presenting  cells  in an antigen-driven  response  (Table  IV).  This 
is  consistent  with  the  work  of Mizel  and  Ben-Zvi  (22)  who  have  demonstrated 
that,  while IL-1 can enhance the proliferation  of primed lymph node cells under 
conditions  where  antigen-presenting  cells  are  limiting,  IL-1  can  not  support  a 
response in the total absence of antigen-presenting cells. In fact, our data strongly 
suggest that  the addition  of soluble antigen  and  IL-1  to a  helper  T  cell  clone is KAYE ET  AL.  847 
TABLE  V 
IL-2-Rich AOFS Supernatant Supports Anti-D  lO-dependent T Cell 
Proliferation in the Absence of Accessory Cells 
Addition * 
Response 
D 10.G4.1 Proliferation:* 
--  Anti-D 10 
HT-2 Prolif- 
eration 0 
--  38  6,001  384 
1% IL-I  38  201,767  180 
25% IL-2  2,234  50,648  43,922 
12% IL-2  957  29,876  30,115 
6% IL-2  447  21,200  13,211 
3% IL-2  94  14,525  12,159 
*  0.2-ml cultures containing 2 ×  10  4 cloned T cells and anti-D10 1:800 or 
no antiserum.  (--); mean cpm ~H-TdR incorporation  of triplicate cul- 
tures pulsed for the final 16 h of a 72-h culture period. 
* Cultures contain  no addition  (--) or various amounts of an IL-l-rich 
P388D1 supernatant  (IL-1) or an IL-2-rich AOFS supernatant  (IL-2). 
00.1_ml  cultures  containing  1 ×  104  HT-2  cells; mean  cpm  3H-TdR 
incorporation  of triplicate cultures pulsed for the final 4 h of a 24-h 
culture period. 
a  very sensitive assay for the presence of contaminating feeder cells. 
If anti-clone sera induce receptivity to IL-2 as well as IL-1, the addition of IL- 
2  should  also  induce  proliferation  in  the  absence  of accessory  cells.  Because 
whole spleen  cell  supernatants  can  potentially contain  IL-1  as well as  IL-2, we 
have used a  Con A-induced T  cell hybridoma (AOFS  21.10.9)  supernatant as a 
source of IL-2 (P.  Marrack, personal communication).  We do not have an assay 
for IL-1 in the presence of contaminating IL-2 but, given its T  cell lineage, it is 
unlikely  that  AOFS  produces  IL-1.  An  AOFS  supernatant  will  induce  the 
proliferation  of the  IL-2-dependent cell line HT-2 (Table V).  Note that an  IL- 
l-rich  P388D1  supernatant  has  no  effect  on  HT-2  cells  demonstrating  the 
absence  of  IL-2  in  this  preparation  (Table  V).  The  experiment  in  Table  V 
demonstrates  that  an  AOFS  supernatant  can  also  support  anti-D10-induced 
D 10.G4.1  proliferation in the absence of accessory cells. The similarity between 
the AOFS supernatant dose response of anti-D 10-induced proliferation and HT- 
2  proliferation  supports  the  interpretation  that  both  are  mediated  by  IL-2. 
However, this response is consistently weaker than  the response to anti-D10  in 
the presence of IL-1  or accessory cells.  We have yet to determine whether  this 
is a quantitative or qualitative difference. In summary, our data suggest that anti- 
clone sera induce receptivity to IL-1 and IL-2. The addition of IL-1 or IL-2 can 
then  induce proliferation,  the former presumably the result of the endogenous 
production of IL-2. 
Anti-D lO Substitutes for Antigen in the Induction  ofT-Dependent Polyclonal B 
Cell Proliferation  and Ig Secretion. 
Helper T  cell clones interact in vitro with B cells to induce B cell proliferation 
and antibody secretion (12).  This interaction  involves the recognition  by the T 
cell of antigen and Ia glycoproteins on the B cell surface. At high antigen doses 
in vitro,  these  interactions  bypass the  B  cell antigen  receptor and  induce poly- 848  STIMULATORY  ANTIBODIES  SPECIFIC  FOR  HELPER  T  CELL  CLONES 
TABLE  VI 
Anti-D  lO Substitutes  for Antigen in the Induction of B Cell Proliferation 
D10*  B Cells*  Ag  a  Addition ! 
Response  I 
D10.G4  D10.G4.1  D10.G4.1 
Exp I  Exp II  Exp III 
-  H-2  k  +  --  22,718  1,517  4,364 
+  H-2  k  -  --  16,262  2,007  6,697 
+  H-2  k  +  --  156,178  40,136  80,392 
+  H-2  k  -  NMS  8,477  ND  ND 
+  H-2  k  -  Anti-D10  92,281  40,625  74,060 
-  H-2  k  -  Anti-D 10  ND  717  2,271 
+  H-2  b  -  --  ND  70,184  63,717 
* 2 x  104 mitomycin C-treated cloned T  cells/0.2 ml culture. 
* AKR/J or BALB.K (H-2k), or C57B1/6  (H-2  b) B cells prepared as described in methods section, 2 
×  l0  s cells/0.2 ml culture. 
200 #g/ml conalbumin (+) or no antigen (-). 
! NMS or anti-D10  1:200-1:800  (concentration of NMS and anti-D10 are identical in an individual 
experiment). 
Mean cpm 3H-TdR incorporation of triplicate cultures, pulsed for the final 4  h  of a  48-h culture 
period. 
cional stimulation. Mitomycin C-treated D 10 will induce syngeneic B cell prolif- 
eration in the presence of conalbumin. D10.G4.1,  which is alloreactive to H-2 b 
(Table I), will  also induce H-2bB cells to proliferate in the absence of antigen 
(Table VI). In the presence of anti-D 10, however, B cells are triggered in a T- 
dependent manner in  the absence of antigen (Table VI).  In contrast to the T 
cell-dependent B cell proliferative response to antigen, this response shows no 
H-2 restriction between D 10 and the B cell (data not shown). 
It was possible that anti-D 10 induced B cell proliferation by the interaction of 
antibody-coated D10 with B cell Fc receptors. Again, our model is the RaMBr 
system in  which  the  T-dependent induction  of B  cell  proliferation  has  been 
reported to be mediated via the Fc (23). Moreover, Lamers et al. found that, at 
very high doses, the monoclonal anti-Fc receptor 2.4G2 would also induce B cell 
proliferation (24). However, the data summarized in Table VII demonstrate that 
2.4G2, at nonstimulating doses, has no effect on the anti-D 10 or antigen response, 
while totally eliminating the RaMBr response. The induction of B cell prolifer- 
ation by anti-clone sera is clone specific. Anti-D8, but not anti-D10, will induce 
D8-dependent  B  cell  proliferation  in  the  absence  of  antigen  (Table  VIII). 
Similarly, anti-D8 has no effect on D10-driven B cell proliferation (Table VIII). 
D10.G4.1  will  also  drive  B  cells  to  secrete antibody  in  an  antigen-specific 
manner. The requirement for antigen is eliminated, however, with the addition 
of anti-D10  (Fig.  4).  Thus,  anti-Dl0  and  anti-D8  have  properties  similar  to 
antigen, but require neither syngeneic Ia nor Fc receptor to activate cloned T 
cells or, in concert with cloned T  cells, to activate B cells. 
Production and Characterization  of a Monoclonal Anti-DlO Antibody. 
The above results demonstrate that one can produce clone-specific antisera 
that replace the need for antigen, Ia, and accessory cells in T  cell activation and 
in T  cell-dependent B cell proliferation. However, they do not demonstrate that KAYE  ET  AL.  849 
TABLE  VII 
Anti-D  tO Does Not Require Interaction with Fc Receptors to Induce 
T-Dependent B Cell Proliferation 
B cell proliferation 
in the presence of: 
D 10.G4.1 *  B Cells  ¢  Addition  0  Anti-FcR  n 
--  + 
-  +  --  1,8741  1,535 
+  +  --  3,187  2,930 
+  +  Conaibumin  79,474  62,745 
+  +  Anti-Dl0  94,251  74,905 
+  +  RaMBr  49,531  1,810 
* 2  X  10  4 mitomycin-treated cloned T  cells/0.2 ml culture. 
* 2  ×  10 5 AKR/J B cells/0.2 ml culture. 
Conalbumin 200 t~g/ml; anti-D10  1:800;  RaMBr  1 : 150. 
! Presence (+) or absence (-) of monoclonal antibody 2.4G2,  1 #g/ml. 
1 Mean cpm SH-TdR incorporation of triplicate cultures, pulsed for the 
final 4 h of a  48-h culture period. 
TABLE  VIII 
Induction of T-Dependent B Cell Proliferation by Anti-Clone Sera is 
Clone Spec~c 
T  Clone*  B Ceils*  Addition  O  Response  I 
D10.G4.1  +  --  4,005 
D 10.G4.1  +  Conalbumin  65,403 
D 10.G4.1  +  Anti-D I 0  59,164 
D 10.G4.1  +  Anti-D8  3,944 
D8  +  --  5,822 
D8  +  OVA  67,606 
D8  +  Anti-D8  56,530 
D8  +  Anti-D10  5,124 
--  +  Conalbumin  3,440 
--  +  OVA  3,500 
--  +  Anti-D 10  1,954 
--  +  Anti-D8  1,084 
* 2 ×  104 mitomycin C-treated cloned T  cells/0.2 ml culture. 
* 2 ×  105 AKR]J B ceils/0.2 ml culture. 
m  Conalbumin and OVA, 200 #g/ml; anti-D10  1:800; anti-D8  1:200. 
! Mean cpm SH-TdR  incorporation of triplicate cultures pulsed for the 
final 4 h  of a 48-h culture period. 
antibody  of a  single  specificity  can  produce  such  effects.  To  approach  this 
problem, BALB.K mice were primed with D10, boosted, and their spleen cells 
fused to  P3X63-Ag8.653  cells  to  produce  monoclonal  antibodies.  One  such 
monoclonal anti-D10 antibody, and its subclones, is shown in  Table  IX.  This 
monoclonal antibody induces D 10.G4.1  to proliferate, while having no effect on 
D8.  Proliferation in  the absence of accessory cells requires IL-1.  The titer of 
culture  supernatant  of this  hybridoma  in  a  functional  assay  is  remarkable; 
supernatant at 1:105 induces D 10.G4.1  proliferation (Table IX). Thus, a mono- 
clonal antibody can replace antigen and Ia-bearing antigen-presenting cells for 850  STIMULATORY  ANTIBODIES  SPECIFIC  FOR  HELPER  T  CELL  CLONES 
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FIGURE 4.  Anti-D10  induces  T-dependent  polyclonal B  cell antibody  secretion.  3  ×  104 
D10.G4.1  were cultured  with  4  ×  105  BALB.K  B  cells in  0.2-ml  cultures  containing;  no 
addition (O), 200 ug/ml conalbumin (I), or anti-D10  1:500 (&). Control cultures contained B 
cells and conalbumin (0) or B cells and anti-D10 (1"7) in the absence of cloned T  cells.  After a 
3-, 4-, or 5-d culture period, triplicate cultures were pooled and assayed in a plaque-forming 
cell assay  using protein A coupled sheep erythrocytes. 
T  cell activation in this system. We are using this monoclonal antibody to isolate 
the molecule, presumed to be the antigen-Ia receptor, from D 10.G4.1  cells. 
Discussion 
In an attempt  to characterize  the  proteins involved in helper  T  cell antigen 
recognition we have raised antisera and a monoclonal antibody in BALB.K mice 
against two AKR-derived cloned helper T  cell lines, D10 and D8. BALB.K anti- 
D10 serum,  BALB.K anti-D8  serum, and monoclonal antibody 3D3 are potent 
inducers of T  cell proliferation.  However, these antibodies react only with the 
immunizing  cell line,  exhibiting  no cross-reactivity between D10 and  D8 cells. 
In addition, anti-D10 serum does not functionally react with normal or mitogen- 
stimulated  AKR  T  cells.  These  results  and  the  fact  that  D10  and  D8  are 
functionally identical but differ in antigen specificity and alloreactivity, suggested 
to  us  that  these antisera  may  react  with  a  variable  portion  of the  antigen/Ia 
receptor(s). Why such an immunization protocol should produce only antibodies 
directed against "idiotypic" and not framework determinants, is unknown. Three 
possibilities are apparent;  a) T  cell receptor constant  regions may be less poly- 
morphic  than  immunoglobulins,  with  no  polymorphism  between  AKR  and 
BALB.K strains;  (b) T  cell receptor allotypes may be poorly immunogenic or (c) 
anti-T  cell receptor allotypes are not detected in the assays used. We have also 
been able to produce a similar anti-D10 activity in two out of four (AKR x  B6)F1 
mice and are currently  testing AKR anti-D 10 sera for activity. White et al.  (2) KAYE  ET  AL.  851 
TABLE  IX 
Clone-specific BALB.K Anti-D lO Monoclonal Antibody 3D3 Induces T Cell 
Proliferation;  Proliferation  is Accessory Cell-independent in the Presence of an 
IL- l-rich Supernatant 
IL-1- 
Exp  T  Clone*  Rich  Antibodyg  Response  !  superna- 
tant  * 
I.  DI0.G4.1  -  --  162 
D 10.G4.1  +  --  295 
D10.G4.1  -  3D3  1:20  7,194 
D10.G4.1  +  3D3 1:20  100,100 
D10.G4.1  -  Anti-D10  1,421 
D10.G4.1  +  Anti-D10  80,681 
D8  +  --  232 
D8  +  Anti-D8  58,284 
D8  +  3D3  1:20  170 
II.  D10.G4.1  -  --  134 
D10.G4.1  +  --  176 
D10.G4.1  -  3D3  1:100  3,080 
D10.G4.1  +  3D3 1:100  105,313 
D10.G4.1  +  3D3  1:12,500  116,280 
D 10.G4.1  +  3D3.1  1:20  114,080 
D10.G4.1  +  3D3.2 1:20  149,600 
III.  D 10.G4.1  -  --  567 
D 10.G4.1  +  --  1,599 
D10.G4.1  -  3D3  1:105  1,118 
D10.G4.1  +  3D3  1:105  57,518 
D10.G4.1  +  3D3  1:106  457 
* 2 ×  104 cloned T cells cultured in 0.2 ml. 
* Presence (+)or absence (-)of 2% IL-l-rich P388D1  supernatant. 
0 Anti-D10 1:8,000;  anti-D8 1:200; 3D3 is a monoclonal BALB.K anti-D10 hybridoma 
culture supernatant; 3D3.1  and 3D3.2 are agar clones of 3D3. 
Mean cpm 3H-TdR incorporation of triplicate cultures pulsed for the final 16 h of a 
72-h culture period. 
also found few limitations in the strain combinations capable of producing specific 
blocking antibodies directed against helper T  cell hybrids. Thus, genetic mapping 
of the determinants  recognized by these sera has, so far, been impossible. 
Binz and  Wigzell (24)  have reported  T  cell proliferation induced  by a  heter- 
oantiserum raised against putative T  cell allo-receptors and Infante et al. (1) have 
described activation of alloreactive clones with  "antiidiotypic" sera.  The  ability 
of anti-D10  and  anti-D8  to  stimulate  T  cells  has  allowed  us  to  compare  the 
activation of T  helper cells by antigen and Ia with that induced by putative anti- 
antigen/Ia  receptor  antibodies.  The  anti-D10  or  anti-D8  induction  of T  cell 
proliferation is dependent  on accessory cells. Splenic adherent  cells are enriched 
for these accessory cells, as well as for antigen-presenting cells. The  requirement 
for accessory cells, however, is eliminated in the presence of IL-1. Taken  together 
these results suggest that the accessory cell for an anti-D10 or anti-D8 response 
may be an  IL-l-producing  antigen-presenting cell. We have not yet determined 
whether  the  accessory  cells  involved  also  express  Ia  molecules.  The  accessory 
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onstrated by blocking studies with monoclonal antibody 2.4G2.  Anti-D10 may 
therefore  activate  D10  to  induce,  via  a  soluble  mediator  or  directly,  IL-1 
production from the accessory cell population.  The lack of genetic restriction 
between the  T  cell  and  accessory cell  in  antibody-mediated responses  would 
suggest that if direct cell contact is required, it is not mediated through a specific 
Ia  recognition  event.  However,  we  have  not  ruled  out  the  possibility  that 
recognition  of nonpolymorphic portions  of  Ia  molecules  is  involved  in  this 
process. Mitogen activation of T  cells also appears to involve induction of IL-1 
from an accessory cell population in the absence of specific Ia recognition (26). 
Our data also suggest that anti-D 10 will induce receptivity to IL-2, independently 
of IL-1. It is unlikely, however, that when anti-D10 induces proliferation in the 
presence of accessory cells that this is the result of accessory T  cell-released IL- 
2, since adherent cells are enriched for accessory cells. In addition, anti-Thy-1 
and complement-treated spleen cells are not depleted of accessory cells for an 
anti-D 10-response although deficient in IL-2 production induced by Con A (data 
not shown). By analogy, the induction of receptivity to IL-2 by antigen and Ia 
may also be the result of direct activation, independent of IL-1. Meuer et al. (3) 
have described a monoclonal antibody specific for an individual cloned human 
cytolytic T  cell line which, although it inhibits antigen-induced proliferation, also 
induces increased receptivity to IL-2. 
Infante et al.  (1)  have described similar clone-specific antisera raised against 
alloreactive T  cell  clones.  These antisera induce IL-2  production  and  T  cell 
proliferation (although variably) in the absence of accessory cells, and therefore 
apparently independent of IL-1. We are currently testing the requirements for 
the induction of IL-2 secretion by the antibodies described here. The antisera 
we have prepared also induce low level proliferation, in some experiments, in 
the absence of added accessory cells. However, minor feeder cell contamination 
of the cloned T  cell population can create the appearance of an accessory cell- 
independent response. In experiments in which soluble antigen and IL-1 did not 
induce T  cell proliferation, the anti-D10 or anti-D8 response in the absence of 
IL-1  was negligible (Table  IV).  These  findings also clarify an  issue raised by 
Durum  and  Gershon  (15).  These  authors  proposed  that  Ia  recognition  was 
required in antigen-driven T  cell proliferation only for the induction of IL-1 
secretion. Our more discriminating system, using cloned antigen-Ia specific T 
cells and IL-1, demonstrates that IL-1  and antigen are not sufficient for T  cell 
activation. Thus, Ia is required for antigen recognition by helper T  cells. 
We have also demonstrated that a monoclonal antibody can induce D 10.G4.1 
proliferation.  This  finding  may  have  profound  implications  concerning  the 
mechanism of activation  of helper  T  cells  by antigen  in  association  with  Ia 
molecules. Anti-immunoglobulin sera activate B cells, but only at concentrations 
well above the saturation  level of binding (27).  In addition,  cross-linking of B 
cell surface immunogiobulin seems to  be  involved in  this  triggering process. 
Unless there are multiple determinants recognized by 3D3  on a  single target 
molecule, monoclonal antibody 3D3  could not extensively cross-link the T  cell 
surface. Also, based on the titer of 3D3 culture supernatants, very low concen- 
trations of antibody are sufficient to activate the T  cell. If indeed this antibody 
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complexes may therefore be more analagous to the interaction of a  hormone 
with its receptor than to the interaction of a multi-determinant antigen with B 
cell surface immunoglobulin.  Anti-hormone receptor antibodies can,  in  some 
systems, mimic the hormone in the activation of a target cell and, in fact, cause 
pathology by this mechanism in autoimmune disease (28). 
RaMBr  sera  are  also  mitogenic  for  D10  and  D8.  These  sera  recognize a 
nonpolymorphic determinant on the Thy-1  molecule (29).  Although BALB.K 
and AKR strains are allelic at the Thy-1 locus, anti-D10 and anti-D8 mitogenic 
activities are not the result ofanti-Thy-1 antibodies for the following reasons: (a) 
D 10 and D8 are both Thy-1.1 +1.2- but anti-D 10 and anti-D8 are clone specific; 
(b) AKR Con A  blasts  or the Thy-l.1 + thymoma BW5147  do not absorb out 
anti-D10 mitogenic activity while removing anti-Thy-1  mitogenic activity from 
RaMBr and anti-Thy-1 cytotoxic activity from anti-D10; (c) (AKR x  B6)F1 anti- 
D10  is  also  mitogenic for  D10  but  not  D8;  and  (d)  under conditions where 
RaMBr immunoprecipitates Thy-1 from surface-iodinated D10.G4.1,  BW5147 
absorbed anti-D 10, while still biologically active, does not (data not shown). It is 
possible,  though, that Thy-1  acts as a  carrier protein, increasing the immuno- 
genicity of the AKR T  cells. 
The finding that anti-clone sera substitute for antigen and Ia in the helper T 
cell-dependent activation of B cells is novel. Blocking studies with 2.4G2 suggest 
that  B  cell activation  in  this  system is  not mediated through an  Fc receptor. 
Other  possible  mechanisms of B  cell  activation,  particularly the  release  of a 
soluble factor, are currently under investigation. We plan to extend these studies 
to include antigen-specific responses, and an examination of the activation state 
of B cells capable of responding to T  helper cells activated by these antisera. The 
fact that anti-D 10  and anti-D8 exhibit clone specificity in the induction of T- 
dependent B  cell activation suggests that these antisera are reacting with the 
same determinant to  induce both  T  cell  and  T-dependent  B  cell  activation. 
Preliminary studies with the monoclonal anti-D 10 antibody have confirmed this 
(data not shown). 
In preliminary biochemical studies using biosynthetically labeled cloned T cells 
we have found that these antisera precipitate a number of proteins. One protein 
is precipitated by anti-D10 from D10, but not D8 cells. Two-dimensional SDS- 
PAGE analysis (first dimension nonreducing, second dimension reducing condi- 
tions) reveals that this protein has an apparent molecular weight of 80,000 and 
is comprised of 40,000-dalton disulfide bonded subunits. Similar findings have 
been reported by two other laboratories using clone-specific monoclonal anti- 
bodies (3, 30). Two-dimensional gel analysis (first dimension nonequilibrium pH 
gradient electrophoresis, second dimension SDS-PAGE) of anti-D 10 immunopre- 
cipitates reveals that this protein is a  heterodimer consisting of an acidic and a 
basic subunit.  Immunoprecipitation studies using the clone-specific monoclonal 
anti-D10  antibody  3D3  have  yielded  similar  results.  A  protein  with  similar 
characteristics has previously been isolated from a  T  cell tumor and was also 
demonstrated to be a constituent of normal T  cells (31). 
These studies demonstrate that cloned T  cell lines can be activated by clone- 
specific antibodies, including a monoclonal antibody, in the complete absence of 
other cell types, provided exogenous IL-1  (or IL-2) is added. Thus, this system 854  STIMULATORY ANTIBODIES SPECIFIC FOR  HELPER T  CELL CLONES 
is  ideally suited  for the biochemical analysis of the complex process  of T  cell 
activation, as only a  single, cloned cell type is present. These antibodies should 
also serve as a  means for isolating and characterizing the receptor involved in 
antigen-Ia recognition. 
Summary 
Two  antisera  and  a  monoclonal  antibody  raised  in  BALB.K  mice  against 
cloned,  major  histocompatibility  complex  (MHC)-restricted,  antigen-specific 
helper  T  cell  lines are  described.  These  antibodies are  specific for individual 
cloned T  cell lines and are potent inducers of T  cell proliferation. The induction 
of T  cell proliferation by these antibodies requires the presence of an adherent 
accessory cell.  There  is  no  H-2  restriction  between  this accessory cell and  the 
cloned T  cell, nor is this antibody-induced proliferation blocked by a monoclonal 
anti-Fc receptor antibody. The  requirement for an accessory cell,  however,  is 
eliminated in the presence of an IL-1- or IL-2-rich supernatant. Thus this system 
allows the analysis of helper T  cell activation with only a single cell type present. 
Anti-T cell sera also induce T  cell-dependent B cell proliferation and immun0- 
globulin secretion. The induction of T  cell-dependent B cell activation by these 
sera does not require  H-2-matched T  cells and B cells. The specificity of these 
antibodies and their ability to stimulate cloned helper T  cells in the absence of 
antigen and antigen-presenting cells strongly suggest that these antibodies are 
directed against antigen and/or Ia recognition sites on the T  ceil. 
The authors wish to thank Pat Conrad and Barbara Broughton for technical support, and 
Maureen Wescott and Diane Mierz for help in generation of the monoclonal antibody. 
We also thank Ira Mellman and Pippa Marrack for gifts of cells and antibodies, and Scott 
Durum for generously supplying IL-l-rich supernatants. 
Received for publication 21 April 1983 and in revised  form 13June 1983. 
References 
1.  Infante, A.J., P. D. Infante, S. Gillis, and C. G. Fathman. 1982.  Definition ofT cell 
idiotypes using anti-idiotypic antisera produced by immunization with T  cell clones. 
J. Exp. Med.  155:1100. 
2.  White,J., K. M. Haskins, P. Marrack, andJ. Kappler. 1983. Use of I region-restricted, 
antigen-specific T  cell  hybridomas to  produce  idiotypically specific  anti-receptor 
antibodies. J. hnmunol.  130:1033. 
3.  Meuer, S. C., K. A. Fitzgerald, R. E. Hussey, J. C. Hodgdon, S. F. Schlossman,  and 
E. L. Reinherz.  1983.  Clonotypic structures involved in antigen-specific human T 
cell function.J. Exp. Med.  157:705. 
4.  Lancki, D. W., M. I. Lorber, M. R. Loken, and F. W. Fitch. 1983.  A clone-specific 
monoclonal antibody that inhibits cytolysis of a cytolytic T  cell clone. J.  Exp.  Med. 
157:921. 
5.  Sredni,  B.,  H.  Y.  Tse,  and  R.  H.  Schwartz.  1980.  Direct  cloning and  extended 
cultures of antigen-specific, MHC restricted,  proliferating T  lymphocytes. Nature 
(Lond.).  283:581. 
6.  Janeway, C. A.,Jr., E. A. Lerner, P.J. Conrad, and B. Jones. 1982. The precision of 
self and non-self major histocompatibility complex encoded antigen recognition by 
cloned T  cells. Behri~g h~st. Mitt.  70:200. KAYE ET AL.  855 
7.  Wigzell, H.  1976. Specific affinity fractionation of lymphocytes using glass or plastic 
bead columns. In In  Vitro  Methods on Cell-Mediated and Tumor Immunity. B. R. 
Bloom andJ. R. David, editors. Academic Press, Inc., New York. p. 245-255. 
8.  Marion, T. N., and D. E. Briles.  1981. Analysis  of autoimmune anti-DNA antibody 
responses using  somatic cell hybridization. In  Monoclonal Antibodies and T  Cell 
Hybridomas. G.J. Hammerling, U. Hammerling, and J. F.  Kearney, eds. Elsevier/ 
North-Holland, New York. p. 251-258. 
9.  Mellman,  I.  S.,  and J.  C.  Unkeless.  1980.  Purification of a  functional mouse  Fc 
receptor through the use of a monoclonal antibody. J. Exp. Med.  152:1048. 
10.  Jones,  B.,  and C.  A. Janeway, Jr.  1981.  Functional activities of antibodies against 
brain-associated T cell antigens. I. Induction of T  cell proliferation. Eur. J. Immunol. 
11:584. 
11.  Steinman, R. M., G. Kaplan, M. D. Witmer, and Z. A. Cohn.  1979. Identification of 
a novel cell type in peripheral lymphoid organs of mice.J. Exp. Med.  149:1. 
12.  Jones,  B.,  and C.  A. Janeway, Jr.  1981. Cooperative interaction of B lymphocytes 
with  antigen-specific  helper  T  lymphocytes  is  MHC  restricted.  Nature  (Lond.). 
292:547. 
13.  Gronowicz, E.,  A.  Coutinho, and  F.  Melchers.  1976.  A  plaque  assay  for all  cells 
secreting Ig of a given type or class. Eur. J. hnmunol. 6:588. 
14.  Gillis, S., M. Ferm, W. Ou, and K. Smith. 1978. T  cell growth factor: parameters of 
production and a quantitative microassay for activity. J. Immunol.  120:2027. 
15.  Durum, S. K., and R. K. Gershon.  1982. Interleukin 1 can replace the requirement 
for I-A-positive cells in the proliferation of antigen-primed T  cells. Proc. Natl. Acad. 
Sci. USA. 79:4747. 
16.  Bottomly, K.,  B. Jones, J.  Kaye, and F. Jones III.  Subpopulations of B cells distin- 
guished by cell surface expression of Ia antigens:correlation of Ia and idiotype during 
activation by cloned Ia-restricted T  cells. J. Exp. Med. 97:265. 
17.  Larsson, E., and A Coutinho.  1980. Mechanism of T  cell activation. I. A screening 
of"step one" ligands. Eur. J. hnmunol.  10:93. 
18.  Germain, R. N. 1981. Accessory cell stimulation ofT cell proliferation requires active 
antigen processing,  la-restricted antigen presentation,  and a  separate non-specific 
2nd signal.J, hnmunol.  I27:1964. 
19.  Sunshine, G. H., D. R. Katz, and M. Feldmann.  1980. Dendritic cells induce T  cell 
proliferation to synthetic antigens under Ir gene control. J. Exp. Med.  152:1817. 
20.  Blyden, G., and R. E. Handschumacher. 1977. Purification and properties of human 
lymphocyte activating factor (LAF). J. Immunol.  118:1631. 
21.  Moller, G. (editor). 1982. Interleukins and lymphocyte activation. Immunol. Rev. Vol. 
63. 
22.  Mizel,  S.  B.,  and  A.  Ben-Zvi.  1980.  Studies on  the  role of lymphocyte-activating 
factor (Interleukin 1) in antigen induced lymph node lymphocyte proliferation. Cell. 
Immunol. 54:382. 
23.  Jones,  B.  1982.  Functional activities of antibodies against  brain-associated  T  cell 
antigens. II. Stimulation ofT cell-induced B cell proliferation. Eur. J. Immunol.  12:30. 
24.  Lamers, M.  C., S.  E.  Heckford, and H.  B.  Dickler.  1982.  Monoclonal anti-Fc IgG 
receptor antibodies trigger B lymphocyte function. Nature (Lond.). 298:178. 
25.  Binz, H., and H. Wigzell.  1981. T  cell receptors with allo-major histocompatibility 
complex specificity from rat and mouse. J. Exp. Med.  154:126 I. 
26.  Rock, K. L.  1982. The role of Ia molecules on the activation of T  lymphocytes. J. 
Immunol.  129:1360. 
27.  Sieckmann, D.  G.,  R.  Asofsky, D.  E.  Mosier, I.  M.  Zitron, and W.  E.  Paul.  1978. 
Activation  of mouse  lympbocytes by  anti-immunoglobulin.  I.  Parameters  of the 856  STIMULATORY ANTIBODIES SPECIFIC  FOR  HELPER  T  CELL  CLONES 
proliferative response. J. Exp. Med.  147:814. 
28.  Kahn,  C.  R.,  M.  Kasuga,  G.  L.  King,  and  C.  Grunfeld.  1982.  Autoantibodies  to 
insulin receptors in man: immunological determinants and mechanism of action. In 
Receptors, Antibodies and Disease. Ciba Foundation Symposium, 90. D. Evered and 
J. Whelan, editors. Pitman Books Ltd., London. p. 91. 
29.  Jones, B.  1983.  Evidence that the Thy-1 molecule is the target for T-cell mitogenic 
antibody against brain-associated antigens. Eur. J. Immunol.  In press. 
30.  Haskins, K., R. Kubo, J. White, M.  Pigeon, J. Kappler, and P. Marrack. The MHC- 
restricted antigen  receptor on T  cells.  I. Isolation with a  monocional antibody. J. 
Exp. Med.  96:1149. 
31.  Allison, J. P., B. W. McIntyre, and D. Bloch. 1982. Tumor-specific antigen of murine 
T-lymphoma defined with monoclonal antibody. J. lmmunol.  129:2293. 